These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25941624)

  • 1. Drug resistance analysis by next generation sequencing in Leishmania.
    Leprohon P; Fernandez-Prada C; Gazanion É; Monte-Neto R; Ouellette M
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):26-35. PubMed ID: 25941624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene amplification in amphotericin B-resistant Leishmania tarentolae.
    Singh AK; Papadopoulou B; Ouellette M
    Exp Parasitol; 2001 Nov; 99(3):141-7. PubMed ID: 11846524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Post-) Genomic approaches to tackle drug resistance in Leishmania.
    Berg M; Mannaert A; Vanaerschot M; Van Der Auwera G; Dujardin JC
    Parasitology; 2013 Oct; 140(12):1492-505. PubMed ID: 23480865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.
    Gazanion É; Fernández-Prada C; Papadopoulou B; Leprohon P; Ouellette M
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3012-21. PubMed ID: 27162331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilocus microsatellite typing of Leishmania and clinical applications: a review.
    Aluru S; Hide M; Michel G; Bañuls AL; Marty P; Pomares C
    Parasite; 2015; 22():16. PubMed ID: 25950900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cos-Seq: A High-Throughput Gain-of-Function Screen for Drug Resistance Studies in Leishmania.
    Potvin JE; Leprohon P; Gazanion E; Sharma M; Fernandez-Prada C; Ouellette M
    Methods Mol Biol; 2019; 1971():141-167. PubMed ID: 30980302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
    Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
    Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A).
    Singh G; Chavan HD; Dey CS
    Int J Antimicrob Agents; 2008 Jun; 31(6):584-6. PubMed ID: 18456462
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional cloning as a means to identify Leishmania genes involved in drug resistance.
    Clos J; Choudhury K
    Mini Rev Med Chem; 2006 Feb; 6(2):123-9. PubMed ID: 16472181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of antimony resistance in Leishmania.
    Ashutosh ; Sundar S; Goyal N
    J Med Microbiol; 2007 Feb; 56(Pt 2):143-53. PubMed ID: 17244793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics. Leishmania exploit sex.
    Miles MA; Yeo M; Mauricio IL
    Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
    [No Abstract]   [Full Text] [Related]  

  • 12. Leishmania spp.: proficiency of drug-resistant parasites.
    Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
    Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
    Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
    Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug sensitivity of Leishmania species: some unresolved problems.
    Croft SL; Yardley V; Kendrick H
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S127-9. PubMed ID: 12055825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania.
    Mukherjee A; Boisvert S; Monte-Neto RL; Coelho AC; Raymond F; Mukhopadhyay R; Corbeil J; Ouellette M
    Mol Microbiol; 2013 Apr; 88(1):189-202. PubMed ID: 23421749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium and Leishmania: the role of mdr genes in mediating drug resistance.
    Chow LM; Volkman SK
    Exp Parasitol; 1998 Sep; 90(1):135-41. PubMed ID: 9709040
    [No Abstract]   [Full Text] [Related]  

  • 17. Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania.
    Bhattacharya A; Leprohon P; Bigot S; Padmanabhan PK; Mukherjee A; Roy G; Gingras H; Mestdagh A; Papadopoulou B; Ouellette M
    Nat Commun; 2019 Dec; 10(1):5627. PubMed ID: 31819054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct arsenite-resistant variants of Leishmania amazonensis take different routes to achieve resistance as revealed by comparative transcriptomics.
    Lin YC; Hsu JY; Shu JH; Chi Y; Chiang SC; Lee ST
    Mol Biochem Parasitol; 2008 Nov; 162(1):16-31. PubMed ID: 18674569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased glutamate transport in acivicin resistant Leishmania tarentolae.
    Roy G; Bhattacharya A; Leprohon P; Ouellette M
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010046. PubMed ID: 34914690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.